Medications associated with Polycythemia vera
Ingredients whose current FDA labeling lists an association with polycythemia vera, extracted from manufacturer submissions via NIH DailyMed.
Label-linked ingredients
Fedratinib
INREBIC® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondar...
Momelotinib
OJJAARA is indicated for the treatment of intermediate or high‑risk myelofibrosis (MF), including primary MF o...
Pacritinib
VONJO is indicated for the treatment of adults with intermediate or high-risk primary or secondary (post-polyc...
Phosphorus P-32
P32 sodium phosphate is indicated for the treatment of polycythemia vera and is effective for the treatment of...
Ropeginterferon Alfa-2B
BESREMi is indicated for the treatment of adults with polycythemia vera....
Lab tests that investigate polycythemia vera
CBC with Differential
Measures red blood cells, white blood cells, and platelets to help evaluate overall health and detect disorder...
Comprehensive Metabolic Panel (CMP)
Measures 14 substances in the blood to assess kidney and liver function, electrolyte balance, and blood sugar ...
Urinalysis
Examines urine content to help detect urinary tract infections, kidney disease, and diabetes....
Frequently Asked Questions
What medications are used for polycythemia vera?
The medications listed above are associated with polycythemia vera in current FDA-approved labeling as reported by manufacturers through NIH DailyMed. Only a qualified prescriber can determine appropriate treatment.
Do these medications cure polycythemia vera?
This site does not provide treatment advice. The list reflects labeled associations, not recommendations. Discuss options, risks, and benefits with your healthcare provider.
Medical disclaimer: Educational content only. Not medical advice or a treatment recommendation.